Editas Medicine, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
EDIT chart
What traders are saying about $EDIT
Latest postsEditas Medicine, Inc. news
- Editas Medicine, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Editas Medicine Q3 2026 Earnings Results and Report
MarketBeat ·
- Editas Medicine Reports Q3 2026 Results: EPS of -$0.15 Misses Es
GuruFocus ·
- Editas Medicine earnings beat by $0.04, revenue topped estimates
Investing.com ·
- Editas Medicine Q3 Operating Income USD -24.2
Moomoo ·
- EDITAS MEDICINE ($EDIT) Releases Q3 2026 Earnings
Quiver Quantitative ·
- Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance ·
- Editas: Q3 Earnings Snapshot
Yahoo Finance ·
- Editas Medicine Q3 net loss narrows
TradingView ·
- BRIEF-Editas Medicine Q3 Net Income USD -23.393 Million Vs. IBES Estimate USD -27.7 Million
TradingView ·
- Editas Medicine Announces Third Quarter 2026 Results and Business Updates
Yahoo Finance ·
- An experimental gene-editing treatment kept LDL cholesterol down at least 90% for 10 months in primates.
Stock Titan ·
Editas Medicine, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $40.5M | $32.3M | $78.1M | $19.7M |
| Net income | -$160.1M | -$237.1M | -$153.2M | -$220.4M |
| Diluted EPS | $-1.80 | $-2.88 | $-2.02 | $-3.21 |
| Total assets (year end) | $186.5M | $341.6M | $499.2M | $514.3M |
| Cash and equivalents (year end) | $146.6M | $131.5M | $123.7M | $141.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Editas Medicine, Inc.
- Ticker
- EDIT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1650664
Frequently asked questions
What exchange is Editas Medicine, Inc. listed on?
Editas Medicine, Inc. trades on the Nasdaq under the ticker symbol EDIT.
What industry is Editas Medicine, Inc. in?
Editas Medicine, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Editas Medicine, Inc. headquartered?
Editas Medicine, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Editas Medicine, Inc.'s fiscal year end?
Editas Medicine, Inc.'s fiscal year ends on December 31.
How much revenue did Editas Medicine, Inc. report?
Editas Medicine, Inc. reported $40.5M in revenue for calendar year 2025, according to its SEC filings.